Myeloid Malignancy Clinical Trials in Shanghai, Shanghai Municipality
4 recruitingShanghai, Shanghai Municipality, China
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML
Myeloid MalignancyRelapsed/Refractory Acute Myeloid Leukaemia
Ascentage Pharma Group Inc.682 enrolled12 locationsNCT04501120
Recruiting
Phase 1
A Study of GLB-001 in Patients With Myeloid Malignancies
Acute Myeloid LeukemiaMyelodysplastic SyndromesMyelofibrosis+3 more
Hangzhou GluBio Pharmaceutical Co., Ltd.108 enrolled14 locationsNCT06378437
Recruiting
Phase 1Phase 2
A Clinical Trial of TQB3909 Tablets in Combination With Azacitidine for the Treatment of Myeloid Malignancies
Myeloid Malignancy
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.138 enrolled21 locationsNCT07011186
Recruiting
Phase 2
Hypomethylating Agent and Venetoclax After Allo-HSCT in Patients With High-risk Myeloid Malignancies.
Myeloid MalignancyHypomethylating AgentVenetoclax
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine78 enrolled1 locationNCT05841771